Concord Biotech Ltd

NSE: CONCORDBIO · BSE: 543960 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹1,356.00
Market cap: ₹14,186 Cr
Revenue (annual): ₹1,055 Cr
Net profit (annual): ₹260.9 Cr
P/E (TTM): 51.5×Sector 47.4×
Promoter holding: 44.08%+0.00% QoQ
FII holding: 7.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Regulatory Approval 3 Other Announcement 3 Financial Results 3 Board Meeting Date 3 Business Update 2 Bonus Issue 2 Annual General Meeting 2 Management Change 1 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

31 Jul 2026 19:48 IST BSE

Annual General Meeting

Concord Biotech Annual General Meeting

Concord Biotech Ltd held its 41st Annual General Meeting on July 31, 2026, via video conferencing. The company summarized the proceedings and acknowledged participant queries.

Read the filing ↗

7 Jul 2026 15:46 IST BSE

Annual General Meeting

Concord Biotech Annual General Meeting

Concord Biotech Ltd. has issued notice for its 41st AGM on July 31, 2026. The meeting will transact financial statements, dividend, and director appointments via VC/OAVM.

Read the filing ↗